Once retatrutide is approved, we will work to secure insurance coverage for it as well
Research in rodents has shown that mimics like semaglutide alter the reward pathways in the brain, potentially reducing addictions to food, drugs, and tobacco
Duro-Castano A, Borrs C, Herranz-Prez V, Blanco-Ganda MC, Conejos-Snchez I, Armin A, et al
A year of Zepbound therapy can exceed $13,000 through retail pharmacies, and insurers weigh long-term savings against upfront medication costs
These pens are manufactured in standardized doses, which are stepped up gradually over several months to allow the body to adjust to the medication